Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EU-PACT acenocoumarol pharmacogenetic dosing trial
NL-OMON32579Active, not recruiting
- Sponsor
- Utrecht University
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acenocoumarol in Atrial fibrillation (AFib) and venous thromboembolism (VTE) (2 arms), sponsored by Utrecht University. Primary endpoint: Percent time within therapeutic INR range. Started Sep 2010; status: active, not recruiting.
02
Drugs
acenocoumarol
03
Conditions
Atrial fibrillation (AFib)venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON32579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32579.